measurement of cadmium in urine as of creatinine μg/g assessment of ß2-microglobulin as of creatinine. μg/g A spot urine for cadmium and urine ß2-microglobulin will be conducted annually and compared against the worker’s baseline levels measured at the start of the health monitoring process. Action Level Where testing results show a level of a level of 3 µg cadmium or more per gram of creatinine in urine or more than 200 ß2-microglobulin per gram creatinine: μg repeat urine tests should be conducted at the same time of the day to confirm results a medical examination should be performed the person conducting a business or undertaking must review control measures and carry out recommended remedial action the worker must be informed of the results of the health monitoring. The information on cadmium is scant compared with that on urinary cadmium. Cadmium concentration in blood reflects recent exposure over months. The action level is 5 μg/L. Removal Level Where results of urine testing indicate a level of cadmium in urine above 5 µg per gram of creatinine or the level of ß2-microglobulin exceeds 1000 µg per gram creatinine, the following action should be carried out: a medical examination should be performed and the registered medical practitioner should consider whether the worker should be removed from cadmium work tests should be repeated every six months until the level falls below 3 µg cadmium per gram creatinine and ß2-microglobulin is less than 200 µg per gram creatinine the person conducting a business or undertaking should review control measures and carry out recommended remedial action the worker must be informed of the results of health monitoring. Return to Work The worker must not return to cadmium work they have been assessed as medically fit to return to work by the medical practitioner supervising the health monitoring. Medical examination A medical examination should be conducted every two years and will include: medical history and counselling on the additional cadmium burden from smoking
measurement of cadmium in urine as μg/g of creatinine assessment of ß2-microglobulin as μg/g of creatinine. A spot urine for cadmium and urine ß2-microglobulin will be conducted annually and compared against the worker’s baseline levels measured at the start of the health monitoring process. Action Level Where testing results show a level of a level of 3 µg cadmium or more per gram of creatinine in urine or more than 200 μg ß2-microglobulin per gram creatinine: repeat urine tests should be conducted at the same time of the day to confirm results a medical examination should be performed the person conducting a business or undertaking must review control measures and carry out recommended remedial action the worker must be informed of the results of the health monitoring. The information on cadmium is scant compared with that on urinary cadmium. Cadmium concentration in blood reflects recent exposure over months. The action level is 5 μg/L. Removal Level Where results of urine testing indicate a level of cadmium in urine above 5 µg per gram of creatinine or the level of ß2-microglobulin exceeds 1000 µg per gram creatinine, the following action should be carried out: a medical examination should be performed and the registered medical practitioner should consider whether the worker should be removed from cadmium work tests should be repeated every six months until the level falls below 3 µg cadmium per gram creatinine and ß2-microglobulin is less than 200 µg per gram creatinine the person conducting a business or undertaking should review control measures and carry out recommended remedial action the worker must be informed of the results of health monitoring. Return to Work The worker must not return to cadmium work they have been assessed as medically fit to return to work by the medical practitioner supervising the health monitoring. Medical examination A medical examination should be conducted every two years and will include: medical history and counselling on the additional cadmium burden from smoking
cadmium.docx